Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Antibody-Drug Conjugate
Sort By
Newest First
1 / 2
1 / 2
Announcement
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement
World ADC
PR-10-24-NI-77
Nov 08, 2024
ADC
World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda
World ADC
PR-10-24-NI-37
Oct 10, 2024
Antibody-Drug Conjugates
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
Thomas Rohrer
Samsung Biologics
PAO-11-23-CL-01
Nov 13, 2023
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
Oct 19, 2023
Biomanufacturing
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
Danielle Alvarez
Pharma's Almanac
PAO-11-022-CL-11
Dec 05, 2022
Opioid Conjugate Vaccines
Vaccines Present a Novel Strategy for Opioid Overdose Prevention
Muctarr Sesay, Ph.D.
GBI
PAO-10-022-CL-07
Oct 31, 2022
ADCS
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
Philipp Spycher
Araris Biotech AG
PAO-07-022-CL-01
Jul 07, 2022
Antibody-Drug Conjugates
Accelerating ADC Development with Advanced Payload Intermediates
David Goeddel, Ph.D.
MilliporeSigma
PAO-06-21-CL-11
Jun 24, 2021
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
Jyothi Swamy, Ph.D.; Elizabeth McKee
MilliporeSigma
PAP-Q4-20-CL-014
Dec 09, 2020
Expansion
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
MilliporeSigma
PR-M09-20-NI-14
Sep 11, 2020
Collaboration
AstraZeneca and Daiichi Sankyo Enter Collaboration to Develop and Commercialize New Antibody Drug Conjugate
AstraZeneca
PR-M07-20-NI-41
Jul 27, 2020
Antibody–Drug Conjugates
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Loretta Itri, M.D., F.A.C.P.,; Usama Malik
Immunomedics
PAP-Q2-20-CL-012
Jul 01, 2020
Antibody-Drug Conjugate
Fast-Tracking ADC Development and Commercialization
Matteo Piazza
PROVEO
PAP-Q4-19-CL-003
Dec 06, 2019
Antibody-Drug Conjugate
Increasing the Potency of Antibody–Drug Conjugates
Philipp Spycher
Araris Biotech AG
PAP-Q4-19-CL-008
Dec 06, 2019
Financing
Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million
Araris Biotech AG
PR-M08-19-NI-057
Aug 20, 2019
FDA Approval
Genetech’s Antibody–Drug Conjugate Receives FDA Approval
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M06-19-NI-010
Jun 20, 2019
ADC
Integrating ADC Manufacturing for the Future
Mark Frigerio, Ph.D.; Juan Carlos Cordova, Ph.D.
Abzena
PAP-Q2-2019-CL-002
May 24, 2019
ADC
Speeding up ADC Development With the Right Partner Organization
Courtney Morgret, Ph.D.
AbbVie Contract Manufacturing
PAP-Q2-2019-CL-001
May 24, 2019
Antibody-Drug Conjugates
Rapid Growth in the ADC Market Drives Strategic Partnership Interest
Allan Davidson
Piramal Pharma Solutions
PAP-Q1-2019-CL-031
Mar 12, 2019
ADC
Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing
Ajinomoto Bio-Pharma Services
PR-M12-18-NI-010
Dec 04, 2018
